Sun Pharma arm gets FDA nod for generic of Vimpat; stock up

The scrip opened at Rs. 786 and has touched a high and low of Rs. 798.85 and Rs. 779.5 respectively.

Shares of Sun Pharmaceuticals are currently trading 0.24% higher at Rs. 794.40 on BSE after its subsidiary received tentative approval for generic of Vimpat, according to media reports.

The scrip opened at Rs. 786 and has touched a high and low of Rs. 798.85 and Rs. 779.5 respectively. So far 778885(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 190728.28 crore.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1200.7 on 07-Apr-2015 and a 52 week low of Rs. 706.4 on 24-Nov-2015. Last one week high and low of the scrip stood at Rs. 824.5 and Rs. 790 respectively.

The promoters holding in the company stood at 54.71 % while Institutions and Non-Institutions held 35.62 % and 9.68 % respectively.

The stock is currently trading below its 200 DMA.